Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary

(2014)   Diabetes & Vascular Disease Research

Standards of Medical Care in Diabetes--2014

(2013)   DIABETES CARE

Summarizing the FIELD study: lessons from a ‘negative' trial

(2013) Vasilis Tsimihodimos et al.   EXPERT OPINION ON PHARMACOTHERAPY

Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: A clinical update

(2013) Ž. Reiner   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Pharmacologic Prevention of Microvascular and Macrovascular Complications in Diabetes Mellitus

(2012) Nikhil Tandon et al.   American Journal of Cardiovascular Drugs

Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction

(2012) Alexander Tenenbaum et al.   Cardiovascular Diabetology

The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus

(2012) Peter P Toth et al.   Cardiovascular Diabetology

Glycemic Control and Cardiovascular Disease: What’s a Doctor to Do?

(2012) Preeti Kishore et al.   Current Diabetes Reports

Standards of Medical Care in Diabetes--2013

(2012)   DIABETES CARE

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

(2011) M. John Chapman et al.   EUROPEAN HEART JOURNAL

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Diabetic dyslipidemia: extending the target beyond LDL cholesterol

(2010) Stephen J. Nicholls et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up

(2010) A. Langsted et al.   JOURNAL OF INTERNAL MEDICINE

Managing diabetic dyslipidemia: Beyond statin therapy

(2009) Hemanth Neeli et al.   Current Diabetes Reports

Triglycerides and HDL Cholesterol: Stars or second leads in diabetes?

(2009) R. Bitzur et al.   DIABETES CARE

Metformin: diamonds are forever

(2009) N Papanas et al.   EXPERT OPINION ON PHARMACOTHERAPY

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia

(2008) Jean-Charles Fruchart et al.   AMERICAN JOURNAL OF CARDIOLOGY

Metformin therapy and clinical uses

(2008) John HB Scarpello et al.   Diabetes & Vascular Disease Research

Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

(2008) Peter Gæde et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results

(2008) Chao-Yung Wang et al.   TRENDS IN MOLECULAR MEDICINE